RBC Capital analyst Arun Viswanathan maintained a Buy rating on Chemours Company (NYSE:CC) on Wednesday, setting a price target of $35, which is approximately 8.29% above the present share price of $32.32.
Viswanathan expects Chemours Company to post earnings per share (EPS) of $0.58 for the third quarter of 2021.
The current consensus among 12 TipRanks analysts is for a Moderate Buy rating of shares in Chemours Company, with an average price target of $39.92.
The analysts price targets range from a high of $48 to a low of $34.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $1.44 billion and a net profit of $138 million. The company's market cap is $5.35 billion.
According to TipRanks.com, RBC Capital analyst Arun Viswanathan is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 9.9% and a 60.95% success rate.
The Chemours Co . is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment produces titanium dioxide. The Fluoroproducts segment supplies refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment provides chemicals used in gold production, oil refining, agriculture, and industrial polymers. The firm offers refrigerants, industrial fluoropolymer resins, sodium cyanide, performance chemicals and intermediates, and titanium dioxide pigments to the plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining markets. The company was founded on February 18, 2014 and is headquartered in Wilmington, Delaware.